106 related articles for article (PubMed ID: 25524880)
41. ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer.
Choi JA; Kwon H; Cho H; Chung JY; Hewitt SM; Kim JH
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615043
[TBL] [Abstract][Full Text] [Related]
42. Biological characteristics and construction of stable ALDH-1 knock-down Hela cell lines.
Liu L; Yi J; Zhang D; Zhang D; Chen S; Li X; Qin J; Wang M; Wang M; Lin Z
Eur J Gynaecol Oncol; 2016; 37(3):357-61. PubMed ID: 27352564
[TBL] [Abstract][Full Text] [Related]
43. Retinal Targets ALDH Positive Cancer Stem Cell and Alters the Phenotype of Highly Metastatic Osteosarcoma Cells.
Mu X; Patel S; Mektepbayeva D; Mahjoub A; Huard J; Weiss K
Sarcoma; 2015; 2015():784954. PubMed ID: 26819566
[TBL] [Abstract][Full Text] [Related]
44. Tumoral heterogeneity in neuroblastoma.
Gomez RL; Ibragimova S; Ramachandran R; Philpott A; Ali FR
Biochim Biophys Acta Rev Cancer; 2022 Nov; 1877(6):188805. PubMed ID: 36162542
[TBL] [Abstract][Full Text] [Related]
45. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract][Full Text] [Related]
46. Retinoic acid receptors: from molecular mechanisms to cancer therapy.
di Masi A; Leboffe L; De Marinis E; Pagano F; Cicconi L; Rochette-Egly C; Lo-Coco F; Ascenzi P; Nervi C
Mol Aspects Med; 2015 Feb; 41():1-115. PubMed ID: 25543955
[TBL] [Abstract][Full Text] [Related]
47. Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.
Triscott J; Rose Pambid M; Dunn SE
Stem Cells; 2015 Apr; 33(4):1042-6. PubMed ID: 25588723
[TBL] [Abstract][Full Text] [Related]
48. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
[TBL] [Abstract][Full Text] [Related]
49. Spectral overlap-free quantum dot-based determination of benzo[a]pyrene-induced cancer stem cells by concurrent monitoring of CD44, CD24 and aldehyde dehydrogenase 1.
Shim Y; Song JM
Chem Commun (Camb); 2015 Feb; 51(11):2118-21. PubMed ID: 25536409
[TBL] [Abstract][Full Text] [Related]
50. The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells.
Fan F; Bellister S; Lu J; Ye X; Boulbes DR; Tozzi F; Sceusi E; Kopetz S; Tian F; Xia L; Zhou Y; Bhattacharya R; Ellis LM
Br J Cancer; 2015 Feb; 112(3):539-46. PubMed ID: 25535733
[TBL] [Abstract][Full Text] [Related]
51. Ethanol modulates the synthesis and catabolism of retinoic acid in the rat prostate.
Fioruci-Fontanelli BA; Chuffa LG; Mendes LO; Pinheiro PF; Justulin LA; Felisbino SL; Martinez FE
Reprod Toxicol; 2015 Jun; 53():1-9. PubMed ID: 25724388
[TBL] [Abstract][Full Text] [Related]
52. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer.
Opdenaker LM; Arnold KM; Pohlig RT; Padmanabhan JS; Flynn DC; Sims-Mourtada J
Breast Cancer (Dove Med Press); 2014; 6():205-9. PubMed ID: 25540596
[TBL] [Abstract][Full Text] [Related]
54. A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma.
Penter L; Maier B; Frede U; Hackner B; Carell T; Hagemeier C; Truss M
Target Oncol; 2015 Dec; 10(4):523-33. PubMed ID: 25559288
[TBL] [Abstract][Full Text] [Related]
55. Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation.
Nakaguro M; Kiyonari S; Kishida S; Cao D; Murakami-Tonami Y; Ichikawa H; Takeuchi I; Nakamura S; Kadomatsu K
Cancer Sci; 2015 Mar; 106(3):237-43. PubMed ID: 25557119
[TBL] [Abstract][Full Text] [Related]
56. Diethylaminobenzaldehyde is a covalent, irreversible inactivator of ALDH7A1.
Luo M; Gates KS; Henzl MT; Tanner JJ
ACS Chem Biol; 2015 Mar; 10(3):693-7. PubMed ID: 25554827
[TBL] [Abstract][Full Text] [Related]
57. Single amino acid polymorphism in aldehyde dehydrogenase gene superfamily.
Priyadharshini Christy J; George Priya Doss C
Front Biosci (Landmark Ed); 2015 Jan; 20(2):335-76. PubMed ID: 25553455
[TBL] [Abstract][Full Text] [Related]
58. Aldehyde dehydrogenase homologous folate enzymes: Evolutionary switch between cytoplasmic and mitochondrial localization.
Krupenko NI; Holmes RS; Tsybovsky Y; Krupenko SA
Chem Biol Interact; 2015 Jun; 234():12-7. PubMed ID: 25549576
[TBL] [Abstract][Full Text] [Related]
59. Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells.
Granit Mizrahi A; Gugenheim A; Hamad H; Hamed R; Tetro N; Maimon O; Khutsurauli S; Nechushtan H; Nisman B; Duran D; Samman W; Birimberg-Schwartz L; Grunewald M; Eyal S; Peretz T
Front Cell Dev Biol; 2023; 11():1217149. PubMed ID: 37954205
[TBL] [Abstract][Full Text] [Related]
60. Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets.
Xia J; Li S; Liu S; Zhang L
MedComm (2020); 2023 Feb; 4(1):e195. PubMed ID: 36694633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
